ByteBrief

Best read upright.

We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.

(We tried widescreen once. It wasn't us.)

ByteBrief

TechFinancial Timesabout 3 hours ago

Silence Therapeutics to Discuss SANRECO Trial Results

1 min read

Silence Therapeutics will host a conference call and webcast to discuss topline results from the Phase 2 SANRECO trial of divesiran in polycythemia vera. The company announcement details the upcoming discussion of the trial's findings.

Level

Hype check

Tap to vote and see what everyone thinks.

#biotech #clinical trial #silence therapeutics

Read full story

More to chew on!

AI5 days ago

QuantHealth Raises $45M Series B

Startups7 days ago

Ratio Therapeutics Raises $70M in Series C Funding

AI6 days ago

Former OpenAI exec Fidji Simo targets POTS cure with AI

Summary by ByteBrief